Insider Selling: Phreesia, Inc. (NYSE:PHR) Director Sells $514,947.60 in Stock

Phreesia, Inc. (NYSE:PHR) Director Michael Weintraub sold 20,565 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $25.04, for a total value of $514,947.60. Following the completion of the transaction, the director now owns 242,827 shares in the company, valued at $6,080,388.08. This trade represents a 7.81 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Michael Weintraub also recently made the following trade(s):

• On Monday, December 16th, Michael Weintraub sold 861 shares of Phreesia stock. The shares were sold at an average price of $25.26, for a total value of $21,748.86.
• On Monday, December 2nd, Michael Weintraub sold 15,152 shares of Phreesia stock. The stock was sold at an average price of $21.01, for a total value of $318,343.52.

Phreesia Stock Performance

Shares of Phreesia stock traded down $0.77 during midday trading on Tuesday, hitting $24.87. The company had a trading volume of 463,410 shares, compared to its average volume of 450,575. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $29.16. The business’s 50 day simple moving average is $20.53 and its two-hundred day simple moving average is $21.84. The stock has a market cap of $1.45 billion, a PE ratio of -17.46 and a beta of 0.98. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same quarter in the previous year, the firm posted ($0.58) EPS. The business’s revenue was up 16.6% compared to the same quarter last year. As a group, equities analysts predict that Phreesia, Inc. will post -1.16 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have commented on the stock. JPMorgan Chase & Co. boosted their target price on shares of Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Monday, September 9th. Canaccord Genuity Group reiterated a “buy” rating and issued a $34.00 price objective on shares of Phreesia in a report on Thursday, September 5th. JMP Securities reissued a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Finally, Robert W. Baird decreased their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $29.33.

Institutional Trading of Phreesia

A number of hedge funds have recently modified their holdings of the company. International Assets Investment Management LLC raised its stake in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after acquiring an additional 1,395 shares in the last quarter. nVerses Capital LLC grew its position in Phreesia by 76.5% during the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock worth $64,000 after acquiring an additional 1,300 shares during the last quarter. Lombard Odier Asset Management USA Corp acquired a new stake in Phreesia during the 2nd quarter valued at $202,000. Point72 DIFC Ltd bought a new stake in shares of Phreesia during the second quarter worth $209,000. Finally, XTX Topco Ltd acquired a new stake in shares of Phreesia in the third quarter valued at $247,000. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.